AVASTIN Special Drug Use Surveillance (Recurrent, or metastatic carcinoma of the cervix)
Phase of Trial: Phase IV
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Bevacizumab (Primary)
- Indications Cervical cancer
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 01 Mar 2018 Status changed from active, no longer recruiting to completed.
- 02 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 03 Jun 2016 New trial record